⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methoxymethane SCHEMBL16998540 | 0.89 | — | — | |
| Methoxymethane SCHEMBL12190176 | 0.89 | — | — | |
| Methoxymethane SCHEMBL5707121 | 0.89 | — | — | |
| Methoxymethane SCHEMBL868 | 0.89 | — | — | |
| Isobutane SCHEMBL7741602 | 0.84 | — | — | |
| Methoxymethane SCHEMBL23300783 | 0.80 | — | — | |
| Methoxymethane SCHEMBL4447861 | 0.80 | — | — | |
| Methoxymethane SCHEMBL7766837 | 0.80 | — | — | |
| Methoxymethane SCHEMBL23668283 | 0.80 | — | — | |
| Methoxymethane SCHEMBL7257640 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104350047-B | substituted chroman compounds as calcium sensing receptor modulators | 卢平亚特兰蒂斯控股有限公司 | 2017-05-24 | — | — | CN | disclosed |
| CN-104350047-A | Substituted chroman compounds as calcium sensing receptor modulators | LUPIN LTD | 2015-02-11 | — | — | CN | disclosed |
| CN-101139383-B | C end modification endomorphin 2 | UNIV LANZHOU | 2011-09-07 | — | — | CN | disclosed |
| CN-100378126-C | C-terminally modified endomorphin1 | UNIV LANZHOU (CN) | 2008-04-02 | — | — | CN | disclosed |
| CN-101139383-A | C end modification endomorphin 2 | UNIV LANZHOU (CN) | 2008-03-12 | — | — | CN | disclosed |
| CN-1754890-A | C-terminal modified endomorphin 1, endomorphin 2 | UNIV LANZHOU (CN) | 2006-04-05 | — | — | CN | disclosed |